A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, adenoma, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, gastric cancer, gastric neoplasm, intestinal disorder, lung disorder, lung neoplasm, malignant colon neoplasm, mesothelial neoplasm, mesothelioma, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, stomach disorder, triple-negative breast carcinoma	Recruiting	Phase 1	2026-09-18		NCT07705334

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
SHY Therapeutics	1

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
HonorHealth Research Institute	Scottsdale	United States	36
NEXT Oncology	San Antonio	United States	70
SCRI at HCA HealthONE	Denver	United States	1
The University of Texas MD Anderson Cancer Center	Houston	United States	207